Process View
A form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases, whose actions dismantle a cardiac muscle cell and result in its death. Cardiac muscle cells are striated muscle cells that are responsible for heart contraction.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cardiac muscle cell apoptotic process"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
TBX5 | T-box 5 | 0.680 | ||
INSR | insulin receptor | 0.319 | Human | |
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.271 | ||
GRIN2B | glutamate receptor, ionotropic, N-methyl D-aspartate 2B | 0.216 | ||
IRS1 | insulin receptor substrate 1 | 0.173 | ||
EGFR | epidermal growth factor receptor | 0.119 | ||
EPOR | erythropoietin receptor | 0.111 | ||
SRF | serum response factor (c-fos serum response element-binding transcription factor) | 0.095 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.079 | ||
SIRT3 | sirtuin 3 | 0.078 | ||
PTPRZ1 | protein tyrosine phosphatase, receptor-type, Z polypeptide 1 | 0.061 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.056 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.054 | Human | |
BLOC1S2 | biogenesis of lysosomal organelles complex-1, subunit 2 | 0.051 | ||
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.048 | ||
IRS2 | insulin receptor substrate 2 | 0.045 | ||
PAX8 | paired box 8 | 0.043 | ||
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.039 | ||
GRIA4 | glutamate receptor, ionotrophic, AMPA 4 | 0.035 | ||
GHR | growth hormone receptor | 0.035 | ||
SH2B1 | SH2B adaptor protein 1 | 0.035 | ||
CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 0.035 | ||
PARVA | parvin, alpha | 0.033 | ||
CARD11 | caspase recruitment domain family, member 11 | 0.032 | ||
DLG4 | discs, large homolog 4 (Drosophila) | 0.030 | ||
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | 0.028 | ||
PARVB | parvin, beta | 0.027 | ||
GATA4 | GATA binding protein 4 | 0.026 | ||
STAT5B | signal transducer and activator of transcription 5B | 0.025 | ||
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.022 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.021 | ||
LAT | linker for activation of T cells | 0.021 | ||
MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.020 | ||
C1orf93 | chromosome 1 open reading frame 93 | 0.020 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.018 | ||
ZNF746 | zinc finger protein 746 | 0.017 | ||
GRB14 | growth factor receptor-bound protein 14 | 0.017 | ||
HTT | huntingtin | 0.017 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.017 | ||
GAB2 | GRB2-associated binding protein 2 | 0.017 | ||
CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0.016 | ||
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.016 | ||
CSK | c-src tyrosine kinase | 0.015 | ||
GOLT1B | golgi transport 1B | 0.015 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.015 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.015 | ||
LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.013 | ||
SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.013 | ||
BCR | breakpoint cluster region | 0.013 | ||
PLEKHB2 | pleckstrin homology domain containing, family B (evectins) member 2 | 0.013 | ||
RSU1 | Ras suppressor protein 1 | 0.013 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.013 | ||
ATP6V1D | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D | 0.013 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.012 | ||
SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.012 | ||
DUSP23 | dual specificity phosphatase 23 | 0.012 | ||
TMEM33 | transmembrane protein 33 | 0.012 | ||
GORAB | golgin, RAB6-interacting | 0.012 | ||
ENPP1 | ectonucleotide pyrophosphatase/phosphodiesterase 1 | 0.012 | ||
CYFIP1 | cytoplasmic FMR1 interacting protein 1 | 0.012 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.012 | ||
C15orf29 | chromosome 15 open reading frame 29 | 0.011 | ||
HIPK2 | homeodomain interacting protein kinase 2 | 0.011 | ||
UBE2L3 | ubiquitin-conjugating enzyme E2L 3 | 0.011 | ||
ATP6V1B2 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2 | 0.011 | ||
NEUROG3 | neurogenin 3 | 0.011 | ||
PPP1R9B | protein phosphatase 1, regulatory (inhibitor) subunit 9B | 0.011 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.011 | ||
TRPV6 | transient receptor potential cation channel, subfamily V, member 6 | 0.011 | ||
GYG1 | glycogenin 1 | 0.011 | ||
ZNF133 | zinc finger protein 133 | 0.011 | ||
SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.011 | ||
BAG3 | BCL2-associated athanogene 3 | 0.010 | ||
PRKCA | protein kinase C, alpha | 0.010 | ||
ARPC5 | actin related protein 2/3 complex, subunit 5, 16kDa | 0.010 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.010 | ||
DPH3 | DPH3, KTI11 homolog (S. cerevisiae) | 0.010 | ||
PEA15 | phosphoprotein enriched in astrocytes 15 | 0.010 | ||
JAK3 | Janus kinase 3 | 0.010 | ||
CALCA | calcitonin-related polypeptide alpha | 0.010 |